Common Stock, Shares, Issued of Summit Therapeutics Inc. from 31 Jan 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Summit Therapeutics Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Jan 2018 to 31 Dec 2025.
  • Summit Therapeutics Inc. Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 775,371,200, a 5.1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Summit Therapeutics Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 775,371,200 +37,745,196 +5.1% 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q3 2025 744,442,533 +7,347,568 +1% 30 Sep 2025 10-Q 20 Oct 2025 2025 Q3
Q2 2025 742,806,672 +18,486,471 +2.6% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 741,609,390 +39,634,794 +5.6% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 737,626,004 +35,965,951 +5.1% 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q3 2024 737,094,965 +39,243,657 +5.6% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 724,320,201 +26,634,836 +3.8% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 701,974,596 +4,289,231 +0.62% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 701,660,053 +490,568,628 +232% 31 Dec 2023 10-K 24 Feb 2025 2024 FY
Q3 2023 697,851,308 +496,530,133 +247% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 697,685,365 +599,563,009 +611% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 697,685,365 +599,563,009 +611% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 211,091,425 +113,051,885 +115% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 201,321,175 +103,692,664 +106% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 98,122,356 +770,557 +0.79% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 98,122,356 +15,202,834 +18% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 98,039,540 +15,464,476 +19% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 97,628,511 +30,396,608 +45% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 97,351,799 +30,119,899 +45% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 82,919,522 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 82,575,064 +15,397,010 +23% 31 Dec 2020 10-K/A 21 Dec 2022 2021 FY
Q3 2020 67,231,903 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 67,231,900 30 Jun 2020 8-K 29 Sep 2020 2020 Q2
Q4 2019 67,178,054 +35,100,080 +109% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 32,077,974 +17,365,250 +118% 31 Jan 2019 8-K 29 Sep 2020 2020 Q2
Q4 2017 14,712,724 31 Jan 2018 8-K 29 Sep 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.